Meet new ISAB Board member Jan Hellqvist: “there is a major opportunity for ISAB as a service provider for SME respiratory drug developers”
Posted 27 september 2022 in Okategoriserade
With over 30 years in the life science and pharma industries and deep roots in respiratory, ISAB’s new Board member Jan Hellqvist has extensive experience growing SMEs to…
Read more